3-Indoleacetonitrile CAS 771-51-7 Tsarkake>99.0% (HPLC) Hoton Babban Ingancin Masana'anta

3-Indoleacetonitrile CAS 771-51-7 Tsarkake>99.0% (HPLC) Babban Ingancin Masana'anta

Takaitaccen Bayani:

Sunan Sinadari: 3-Indoleacetonitrile

Saukewa: 771-51-7

Tsafta:> 99.0% (HPLC)

Bayyanar: Rawaya mai haske zuwa Foda mai haske

Kyakkyawan inganci, Samar da Kasuwanci

E-Mail: alvin@ruifuchem.com

Aika mana imel

Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Shanghai Ruifu Chemical Co., Ltd. shine babban masana'anta kuma mai ba da kayayyaki na 3-Indoleacetonitrile (CAS: 771-51-7) tare da babban inganci, samar da kasuwanci.Maraba don yin oda.

Abubuwan Sinadarai:

Sunan Sinadari	3-Indoleacetonitrile
Makamantu	Indole-3-Acetonitrile;2- (1H-Indol-3-yl) acetonitrile
Lambar CAS	771-51-7
Lambar CAT	Saukewa: RF-PI1602
Matsayin Hannun jari	A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta	Saukewa: C10H8N2
Nauyin Kwayoyin Halitta	156.19
Matsayin narkewa	33.0 ~ 36.0 ℃ (lit.)
Yawan yawa	1.1566
Solubility	Mai narkewa a cikin Methanol (Kusan Gaskiya)
Alamar	Ruifu Chemical

Ƙayyadaddun bayanai:

Abu	Ƙayyadaddun bayanai
Bayyanar	Rawaya Mai Haske Zuwa Hasken Foda
Tsarkake / Hanyar Bincike	> 99.0% (HPLC)
Asara akan bushewa	<1.00%
Rashin Tsabtace Guda Daya	<0.50%
Jimlar ƙazanta	<1.00%
1 H NMR Spectrum	Daidaita Da Tsarin
Matsayin Gwaji	Matsayin Kasuwanci
Amfani	Matsakaicin Magunguna

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / Kwali Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi.

Amfani:

FAQ:

Aikace-aikace:

3-Indoleacetonitrile (CAS: 771-51-7),Mai amsawa don shiri na: Tryptophan dioxygenase inhibitors pyridyl-ehenyl-indoles a matsayin m anticancer immunomodulators;Histon deacetylase masu hanawa;Masu hana kinase masu yiwuwa;Kv7/KCNQ masu kunna tashar tashar potassium;Kinesin-Specific MKLP-2 Mai hanawa;Maganin kashe kwari;Abubuwan da za a iya ɗauka na PET ciwon daji;Agonists na Farnesoid X Receptor (FXR) azaman maganin atherosclerosis;Butyrylcholinesterase inhibitors;Necroptosis inhibitors.